{"id":"https://openalex.org/W3206418643","doi":"https://doi.org/10.1111/1346-8138.16188","title":"Topical glycopyrronium tosylate in Japanese patients with primary axillary hyperhidrosis: A randomized, double\u2010blind, vehicle\u2010controlled study","display_name":"Topical glycopyrronium tosylate in Japanese patients with primary axillary hyperhidrosis: A randomized, double\u2010blind, vehicle\u2010controlled study","publication_year":2021,"publication_date":"2021-10-11","ids":{"openalex":"https://openalex.org/W3206418643","doi":"https://doi.org/10.1111/1346-8138.16188","mag":"3206418643","pmid":"https://pubmed.ncbi.nlm.nih.gov/34636057","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9293301"},"language":"en","primary_location":{"id":"doi:10.1111/1346-8138.16188","doi":"https://doi.org/10.1111/1346-8138.16188","is_oa":true,"landing_page_url":"https://doi.org/10.1111/1346-8138.16188","pdf_url":null,"source":{"id":"https://openalex.org/S143887118","display_name":"The Journal of Dermatology","issn_l":"0385-2407","issn":["0385-2407","1346-8138"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Dermatology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1111/1346-8138.16188","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5000565136","display_name":"Hiroo Yokozeki","orcid":"https://orcid.org/0000-0002-5773-9485","observed_orcids":["https://orcid.org/0000-0002-5773-9485"]},"institutions":[{"id":"https://openalex.org/I125602781","display_name":"Tokyo Medical and Dental University","ror":"https://ror.org/051k3eh31","country_code":"JP","type":"education","lineage":["https://openalex.org/I125602781","https://openalex.org/I4400009020"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Hiroo Yokozeki","raw_affiliation_strings":["Department of Dermatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan"],"raw_orcid":"https://orcid.org/0000-0002-5773-9485","affiliations":[{"raw_affiliation_string":"Department of Dermatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan","institution_ids":["https://openalex.org/I125602781"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060059025","display_name":"Tomoko Fujimoto","orcid":"https://orcid.org/0000-0003-0771-3778","observed_orcids":["https://orcid.org/0000-0003-0771-3778"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tomoko Fujimoto","raw_affiliation_strings":["Ikebukuro Nishiguchi Fukurou Dermatology Clinic, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ikebukuro Nishiguchi Fukurou Dermatology Clinic, Tokyo, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027745227","display_name":"Shunsuke Wanatabe","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210157255","display_name":"Maruho (Japan)","ror":"https://ror.org/05hj3gh79","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210157255"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shunsuke Wanatabe","raw_affiliation_strings":["Clinical Development Department, Maruho Co., Ltd., Kyoto, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Development Department, Maruho Co., Ltd., Kyoto, Japan","institution_ids":["https://openalex.org/I4210157255"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103040065","display_name":"Shuhei Ogawa","orcid":"https://orcid.org/0000-0001-7411-6143","observed_orcids":["https://orcid.org/0000-0001-7411-6143"]},"institutions":[{"id":"https://openalex.org/I4210157255","display_name":"Maruho (Japan)","ror":"https://ror.org/05hj3gh79","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210157255"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shuhei Ogawa","raw_affiliation_strings":["Clinical Development Department, Maruho Co., Ltd., Kyoto, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Development Department, Maruho Co., Ltd., Kyoto, Japan","institution_ids":["https://openalex.org/I4210157255"]}]},{"author_position":"last","author":{"id":null,"display_name":"Chie Fujii","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210157255","display_name":"Maruho (Japan)","ror":"https://ror.org/05hj3gh79","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210157255"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Chie Fujii","raw_affiliation_strings":["Clinical Development Department, Maruho Co., Ltd., Kyoto, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Development Department, Maruho Co., Ltd., Kyoto, Japan","institution_ids":["https://openalex.org/I4210157255"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5000565136"],"corresponding_institution_ids":["https://openalex.org/I125602781"],"apc_list":{"value":3630,"currency":"USD","value_usd":3630},"apc_paid":{"value":3630,"currency":"USD","value_usd":3630},"fwci":2.709,"has_fulltext":true,"cited_by_count":17,"citation_normalized_percentile":{"value":0.89726027,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":98},"biblio":{"volume":"49","issue":"1","first_page":"86","last_page":"94"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12625","display_name":"Sympathectomy and Hyperhidrosis Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12625","display_name":"Sympathectomy and Hyperhidrosis Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11109","display_name":"Thermoregulation and physiological responses","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/primary-axillary-hyperhidrosis","display_name":"primary axillary hyperhidrosis","score":0.9539999961853027},{"id":"https://openalex.org/keywords/sweating","display_name":"sweating","score":0.6759999990463257},{"id":"https://openalex.org/keywords/hyperhidrosis-disease-severity-scale","display_name":"Hyperhidrosis Disease Severity Scale","score":0.9929999709129333},{"id":"https://openalex.org/keywords/treatment-emergent-adverse-events","display_name":"treatment-emergent adverse events","score":0.8830000162124634},{"id":"https://openalex.org/keywords/japanese-patients","display_name":"Japanese patients","score":0.6859999895095825},{"id":"https://openalex.org/keywords/treatment-efficacy-and-safety","display_name":"treatment efficacy and safety","score":0.7710000276565552}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8618440628051758},{"id":"https://openalex.org/C2778650131","wikidata":"https://www.wikidata.org/wiki/Q935781","display_name":"Hyperhidrosis","level":2,"score":0.7361876368522644},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.597514271736145},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.5322850346565247},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5144643783569336},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.504203200340271},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.3264418840408325},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.2591606378555298},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.22319760918617249}],"mesh":[{"descriptor_ui":"D001365","descriptor_name":"Axilla","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006024","descriptor_name":"Glycopyrrolate","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006945","descriptor_name":"Hyperhidrosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D007564","descriptor_name":"Japan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1111/1346-8138.16188","doi":"https://doi.org/10.1111/1346-8138.16188","is_oa":true,"landing_page_url":"https://doi.org/10.1111/1346-8138.16188","pdf_url":null,"source":{"id":"https://openalex.org/S143887118","display_name":"The Journal of Dermatology","issn_l":"0385-2407","issn":["0385-2407","1346-8138"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Dermatology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9293301","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9293301/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9293301/pdf/","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Dermatol","raw_type":"Text"},{"id":"pmid:34636057","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34636057","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of dermatology","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1111/1346-8138.16188","doi":"https://doi.org/10.1111/1346-8138.16188","is_oa":true,"landing_page_url":"https://doi.org/10.1111/1346-8138.16188","pdf_url":null,"source":{"id":"https://openalex.org/S143887118","display_name":"The Journal of Dermatology","issn_l":"0385-2407","issn":["0385-2407","1346-8138"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Dermatology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F8020440731","display_name":"Maruho","ror":"https://ror.org/05hj3gh79"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3206418643.pdf","grobid_xml":"https://content.openalex.org/works/W3206418643.grobid-xml"},"referenced_works_count":21,"referenced_works":["https://openalex.org/W2000978869","https://openalex.org/W2022137053","https://openalex.org/W2038915663","https://openalex.org/W2068133922","https://openalex.org/W2081071429","https://openalex.org/W2096991001","https://openalex.org/W2106475808","https://openalex.org/W2170874530","https://openalex.org/W2507750354","https://openalex.org/W2529904056","https://openalex.org/W2545960269","https://openalex.org/W2622220612","https://openalex.org/W2812196991","https://openalex.org/W2898726906","https://openalex.org/W2901780400","https://openalex.org/W2911964349","https://openalex.org/W2945095562","https://openalex.org/W2971808325","https://openalex.org/W2977558392","https://openalex.org/W3009677338","https://openalex.org/W3118599727"],"related_works":["https://openalex.org/W2945095562","https://openalex.org/W2898726906","https://openalex.org/W2812196991","https://openalex.org/W3009677338","https://openalex.org/W2944369791","https://openalex.org/W2985409309","https://openalex.org/W2949873078","https://openalex.org/W6958676926","https://openalex.org/W3120772925","https://openalex.org/W4396788532"],"abstract_inverted_index":{"Glycopyrronium":[0],"tosylate":[1,48,94,106,113,136,176,200,240],"cloth,":[2],"an":[3],"anticholinergic":[4],"drug,":[5],"has":[6],"been":[7,28],"approved":[8],"for":[9,50],"the":[10,18,42,104,111,119,134,174,180,216,231,242],"topical":[11,92,238],"treatment":[12,226],"of":[13,46,63,131,220,237],"primary":[14,51,67],"axillary":[15,52,68],"hyperhidrosis":[16,53,69],"in":[17,23,55,103,110,118,123,133,141,149,167,173,195,230],"USA,":[19],"but":[20],"its":[21],"effects":[22],"Japanese":[24],"patients":[25,54,101,132,196],"have":[26],"not":[27],"previously":[29],"investigated.":[30],"This":[31],"4-week,":[32],"randomized,":[33],"double-blind,":[34],"vehicle-controlled,":[35],"multicenter":[36],"study":[37],"was":[38,228],"conducted":[39],"to":[40,89,225],"evaluate":[41],"efficacy":[43],"and":[44,65,79,116,146,161,205,250],"safety":[45],"glycopyrronium":[47,93,105,112,135,175,199,239],"cloth":[49],"Japan.":[56],"Eligible":[57],"patients,":[58],"who":[59],"were":[60,86,126,201,211],"\u22659":[61],"years":[62],"age":[64],"had":[66],"\u22656":[70],"months,":[71],"with":[72,179,198,254],"gravimetrically-measured":[73],"sweat":[74,150,252],"production":[75,151,253],"\u226550":[76],"mg/5":[77],"min,":[78],"Hyperhidrosis":[80,142,246],"Disease":[81,143,247],"Severity":[82,144,248],"Scale":[83,145,249],"\u22653":[84],"(moderate)":[85],"randomized":[87],"1:1:1":[88],"once":[90],"daily":[91],"3.75%,":[95],"2.5%,":[96],"or":[97],"vehicle.":[98],"Overall,":[99],"497":[100],"(163":[102],"3.75%":[107],"group,":[108,115,121],"168":[109],"2.5%":[114],"166":[117],"vehicle":[120,155,181],"hereinafter":[122],"this":[124],"order)":[125],"randomized.":[127],"Statistically":[128],"higher":[129],"proportions":[130],"groups":[137,177],"achieved":[138],"\u22652-point":[139],"improvement":[140],"\u226550%":[147],"reduction":[148],"from":[152],"baseline":[153],"versus":[154],"at":[156],"week":[157,187],"4":[158],"(51.6%,":[159],"41.1%,":[160],"16.4%,":[162],"respectively;":[163],"p":[164],"<":[165],"0.001":[166],"both":[168],"cases).":[169],"Higher":[170],"responder":[171],"rates":[172],"compared":[178],"group":[182],"occurred":[183],"as":[184,186,213],"early":[185],"1.":[188],"The":[189,218,234],"most":[190],"common":[191],"treatment-emergent":[192,208,221],"adverse":[193,209,222],"events":[194,210,223],"treated":[197],"photophobia,":[202],"mydriasis,":[203],"thirst,":[204],"dysuria.":[206],"Most":[207],"mild":[212],"determined":[214],"by":[215],"investigators.":[217],"incidence":[219],"leading":[224],"modification":[227],"low":[229],"three":[232],"groups.":[233],"4-week":[235],"use":[236],"improved":[241],"patient-reported":[243],"outcome":[244],"measure":[245],"objectively-evaluated":[251],"a":[255],"favorable":[256],"benefit/risk":[257],"profile.":[258]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":4}],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2021-10-25T00:00:00"}